Determine, Inc. (NASDAQ: DTRM) is a leading global SaaS solutions provider in Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM). Recognized by major analysts, our pedigree comes from the merging of talent and experience of three pioneering contract management, sourcing and procurement leaders — Selectica, Iasta and b-pack. Together we set a new industry standard with the Determine Cloud Platform, which our customers leverage to reach PlatformanceSM. Platformance is Determine`s doctrine that empowers customers to achieve enterprise success when people, data and business processes work together in perfect harmony: • Fast integration • Ease of use that speeds user buy-in • Modular solutions that add on as needed without re-implementing • A single source of data truth across the entire enterprise • Business process management tying all solutions and workflows together • Open collaboration for easy-to-add features • Built-in self-service tools that empower all users Unlike point solutions, or “cobbled-together” suites on platforms, our solutions are all integrated, seamless and simple-to-use for faster ROI. With goals aligned, data verified and shareable, and workflows unified, companies are ideally positioned to simplify complexity and attain enterprise-level results: saving money, making money and reducing business risk.
Peter Ritchie Inc. Software Consulting Co. is a Ashton, ON-based company in the Software & Internet sector.
Multimedia Products & Consulting is a Somerset, NJ-based company in the Software and Internet sector.
Mayors Office is a Thermopolis, WY-based company in the Software and Internet sector.
InnovHeart s.r.l., with operations in Colleretto Giacosa (Italy) and Poway (CA-USA), develops the Saturn System, a transcatheter mitral valve replacement (TMVR) platform intended to treat patients suffering from mitral valve disease. Saturn`s unique design allows the clinician to accurately deliver the prosthesis in the anatomically correct position, providing a stable and durable anchorage and sealing to the implant site. The system`s sub-annular ring affords inverse remodeling of the mitral annulus, and the low profile of the prosthesis ensures unimpeded flow from the left ventricle after implantation.